Placental-fetal growth restriction / (Record no. 515522)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05636nam a22003738i 4500 |
| 001 - CONTROL NUMBER | |
| control field | CR9781316181898 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | UkCbUP |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20200124160208.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
| fixed length control field | m|||||o||d|||||||| |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr|||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 140910s2018||||enk o ||1 0|eng|d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781316181898 (ebook) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 9781107101395 (hardback) |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | UkCbUP |
| Language of cataloging | eng |
| Description conventions | rda |
| Transcribing agency | UkCbUP |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RG629.G76 |
| Item number | P53 2018 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 618.3/2 |
| Edition number | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Placental-fetal growth restriction / |
| Statement of responsibility, etc | edited by Christoph Lees, Gerard H. A. Visser, Kurt Hecher. |
| 264 #1 - Production, Publication, Distribution, Manufacture, and Copyright Notice (R) | |
| Place of production, publication, distribution, manufacture (R) | Cambridge : |
| Name of producer, publisher, distributor, manufacturer (R) | Cambridge University Press, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2018. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (xvi, 282 pages) : |
| Other physical details | digital, PDF file(s). |
| 336 ## - Content Type (R) | |
| Content type term (R) | text |
| Content type code (R) | txt |
| Source (NR) | rdacontent |
| 337 ## - Media Type (R) | |
| Media type term (R) | computer |
| Media type code (R) | c |
| Source (NR) | rdamedia |
| 338 ## - Carrier Type (R) | |
| Carrier type term (R) | online resource |
| Carrier type code (R) | cr |
| Source (NR) | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| სერიის ცნობა | Cambridge medicine |
| 500 ## - GENERAL NOTE | |
| General note | Title from publisher's bibliographic system (viewed on 25 Jul 2018). |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Machine generated contents note: Part I. Basic Principles: 1. What is optimal fetal growth? Blanka Vasak and Gerard H. A. Visser; 2. Definition of fetal growth restriction and uteroplacental insufficiency Wessel Ganzevoort and Basky Thilaganathan; 3. Differential diagnosis of fetal growth restriction S. Usman, A. Lawin-O'Brien and Christoph Lees; 4. Fetal growth restriction and hypertensive diseases of pregnancy Christopher W. G. Redman and Anne Cathrine Staff; 5. ART and fetal growth Christoph Brezinka and Shirin Khanjani; 6. Fetal growth restriction - study design and outcomes Hans Wolf and Wessel Ganzevoort; 7. Analysis of national and international guidelines on placental-fetal growth restriction Gemma Malin, Lesley McCowan, K. E. Boers and Jim G. Thornton; Part II. Maternal Cardiovascular Characteristics and the Placenta: 8. Maternal cardiovascular function and fetal growth restriction Rosemary Townsend and Asma Khalil; 9. Placental histopathology findings in fetal growth restriction Neil Sebire and William Mifsud; 10. Maternal volume homeostasis in fetal growth restriction Johannes J. Duvekot; Part III. Screening for PFGR: 11. First trimester combined screening algorithms for fetal growth restriction Rosemary Townsend and Asma Khalil; 12. Second trimester and late pregnancy screening for fetal growth restriction Raffaele Napolitano and Pasquale Martinelli; Part IV. Prophylaxis and Treatment: 13. Prophylaxis for fetal growth restriction: aspirin and low molecular weight heparins Federico Prefumo and Tiziana Frusca; 14. Prophylaxis for fetal growth restriction: nitric oxide donors and sildenafil Dietmar Schlembach; 15. Prevention and Treatment of Fetal Growth Restriction by influencing maternal hemodynamics and blood volume Herbert Valensise, Barbara Vasopollo and Gian Paolo Novelli; 16. Gene therapy in fetal growth restriction Rebecca N. Spencer, David J. Carr and Anna L. David; Part V. Characteristics of Fetal Growth Restriction: 17. Blood flow volume in umbilical vein in fetal growth restriction Enrico Ferrazzi, Daniela Di Martino and Tamara Stampalija; 18. Fetal cardiac function in fetal growth restriction Fatima Crispi and Eduard Gratacos; 19. Heart rate changes and autonomic nervous system in fetal growth restriction S. M. Lobmaier, K. T. M. Schneider and G. H. A. Visser; 20. The fetal arterial and venous circulation in IUGR Kurt Hecher and Werner Diehl; 21 Hematological and biochemical findings in fetal growth restriction and the relationship to hypoxia Irene Cetin and Chiara Mand-; Part VI. Management of Fetal Growth Restriction: 22. Management of early-onset fetal growth restriction (less than 34 weeks) Tullia Todros and Giovanna Ogge;; 23. Late-onset intrauterine growth restriction Katia Bilardo and Francesc Figueras; 24. Severe IUGR: pregnancy management at the limits of viability Aris T. Papageorghiou and Wessel Ganzevoort; 25. Fetal growth restriction in twin pregnancies Isabel Couck, Kurt Hecher and Liesbeth Lewi; Part VII. Postnatal Aspects of Fetal Growth Restriction: 26. Fetal growth restriction and neonatal outcomes R. S. Gandhi and N. Marlow; 27. Fetal growth restriction and later disease in the mother and the offspring Birgit Arabin and Petra Arck; 28. Fetal growth restriction: recurrence risks and counseling Jan Derks and Steven Koenen. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Master the effective evaluation, analysis and management of placental-fetal growth restriction (PFGR), developing strategies to reduce the risk of perinatal mortality and morbidity in patients worldwide. Extensively researched by international experts, this manual provides practitioners with a detailed, hands-on approach to the practical 'pearls' for direct patient management. This authoritative volume advises on matters such as the correct evaluation and management of high-risk patients in danger of PFGR through to delivery. Extensive and wide-ranging, this book is an invaluable companion to the developing research interest and clinical applications in PFGR, including developmental outcomes in early childhood. Featuring a critical evaluation of a variety of abnormal conditions, such as fetal hypoxia and extreme prematurity, which are clearly displayed through extensive illustrations. This essential toolkit ensures that practitioners at all levels can effectively limit adverse outcome and reach the correct diagnosis. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Fetal growth retardation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lees, Christoph, |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Visser, Gerard Hille Adriaan, |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hecher, Kurt, |
| Relator term | author. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Print version: |
| International Standard Book Number | 9781107101395 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Cambridge medicine (Series) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1017/9781316181898">https://doi.org/10.1017/9781316181898</a> |
No items available.